1. Home
  2. SLN vs MED Comparison

SLN vs MED Comparison

Compare SLN & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$6.37

Market Cap

318.4M

Sector

Health Care

ML Signal

HOLD

Logo MEDIFAST INC

MED

MEDIFAST INC

HOLD

Current Price

$12.44

Market Cap

120.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLN
MED
Founded
1994
1980
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
318.4M
120.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SLN
MED
Price
$6.37
$12.44
Analyst Decision
Buy
Hold
Analyst Count
6
1
Target Price
$39.67
$16.50
AVG Volume (30 Days)
305.5K
236.8K
Earning Date
11-06-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.02
Revenue
$25,830,000.00
$429,695,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$619.39
Revenue Growth
40.39
N/A
52 Week Low
$1.97
$10.36
52 Week High
$8.08
$21.11

Technical Indicators

Market Signals
Indicator
SLN
MED
Relative Strength Index (RSI) 47.63 66.06
Support Level $5.95 $10.72
Resistance Level $6.60 $11.12
Average True Range (ATR) 0.53 0.35
MACD -0.04 0.22
Stochastic Oscillator 29.81 94.57

Price Performance

Historical Comparison
SLN
MED

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

About MED MEDIFAST INC

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

Share on Social Networks: